RESEARCHER PROFILE

Wei Wang

← Back to Southern Medical University

W

Southern Medical University

Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and MutationsRespiratory Support and Mechanisms

Wei Wang works in Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, Respiratory Support and Mechanisms. Recorded institutional associations include North China University of Science and Technology, Central South University, Second Military Medical University.

691Publications
21,152Citations
57H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

    2020 · 4,412 citations
  2. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

    2020 · 3,669 citations
  3. Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China

    2020 · 898 citations
  4. Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma.

    2016 · 610 citations
  5. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

    2020 · 456 citations
  6. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China

    2020 · 303 citations
  7. Early triage of critically ill COVID-19 patients using deep learning

    2020 · 276 citations
  8. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

    2022 · 237 citations
  9. Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma

    2020 · 231 citations
  10. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

    2012 · 226 citations
  11. Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials

    2010 · 217 citations
  12. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma

    2019 · 179 citations
  13. Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis

    2019 · 170 citations
  14. Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma ( NIC‐ESCC2019 ): A multicenter, phase 2 study

    2022 · 166 citations
  15. Cigarette smoke-inactivated SIRT1 promotes autophagy-dependent senescence of alveolar epithelial type 2 cells to induce pulmonary fibrosis

    2021 · 160 citations
  16. Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial

    2018 · 151 citations
  17. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer

    2014 · 131 citations
  18. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019–Related Respiratory Failure*

    2021 · 117 citations
  19. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7

    2013 · 116 citations
  20. Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer

    2015 · 114 citations
  21. Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment

    2020 · 113 citations
  22. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling

    2020 · 103 citations
  23. Sub-percent precision measurement of neutrino oscillation parameters with JUNO*

    2022 · 101 citations
  24. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival

    2019 · 96 citations
  25. Macrophage-derived MCPIP1 mediates silica-induced pulmonary fibrosis via autophagy

    2016 · 95 citations

← Return to the university profile